242
Participants
Start Date
September 30, 2008
Primary Completion Date
June 30, 2009
Study Completion Date
June 30, 2009
FlexTouch®
All subjects to receive insulin detemir treatment (and if relevant insulin aspart) with either a insulin pen PDS290 (FlexTouch®) or a Novo Nordisk marketed insulin pen (FlexPen®) for 12 weeks. After 12 weeks, all subjects will continue their insulin treatment with the other injection device.
FlexPen®
All subjects to receive insulin detemir treatment (and if relevant insulin aspart) with either a insulin pen PDS290 (FlexTouch®) or a Novo Nordisk marketed insulin pen (FlexPen®) for 12 weeks. After 12 weeks, all subjects will continue their insulin treatment with the other injection device.
Novo Nordisk Investigational Site, Altoona
Novo Nordisk Investigational Site, Carlisle
Novo Nordisk Investigational Site, Hyattsville
Novo Nordisk Investigational Site, Rockville
Novo Nordisk Investigational Site, Baltimore
Novo Nordisk Investigational Site, Virginia Beach
Novo Nordisk Investigational Site, Tabor City
Novo Nordisk Investigational Site, Asheville
Novo Nordisk Investigational Site, Little River
Novo Nordisk Investigational Site, Roswell
Novo Nordisk Investigational Site, Atlanta
Novo Nordisk Investigational Site, Athens
Novo Nordisk Investigational Site, Savannah
Novo Nordisk Investigational Site, Tallahassee
Novo Nordisk Investigational Site, Maitland
Novo Nordisk Investigational Site, Hollywood
Novo Nordisk Investigational Site, Miami
Novo Nordisk Investigational Site, Miami
Novo Nordisk Investigational Site, Boca Raton
Novo Nordisk Investigational Site, Ocala
Novo Nordisk Investigational Site, Chattanooga
Novo Nordisk Investigational Site, Lexington
Novo Nordisk Investigational Site, Mentor
Novo Nordisk Investigational Site, Kettering
Novo Nordisk Investigational Site, Dayton
Novo Nordisk Investigational Site, Lafayette
Novo Nordisk Investigational Site, Milwaukee
Novo Nordisk Investigational Site, Fargo
Novo Nordisk Investigational Site, Butte
Novo Nordisk Investigational Site, Chicago
Novo Nordisk Investigational Site, Chicago
Novo Nordisk Investigational Site, St Louis
Novo Nordisk Investigational Site, Jefferson City
Novo Nordisk Investigational Site, Wichita
Novo Nordisk Investigational Site, Omaha
Novo Nordisk Investigational Site, Metairie
Novo Nordisk Investigational Site, Dallas
Novo Nordisk Investigational Site, Arlington
Novo Nordisk Investigational Site, Hurst
Novo Nordisk Investigational Site, San Antonio
Novo Nordisk Investigational Site, Aurora
Novo Nordisk Investigational Site, Golden
Novo Nordisk Investigational Site, Colorado Springs
Novo Nordisk Investigational Site, Ogden
Novo Nordisk Investigational Site, Las Vegas
Novo Nordisk Investigational Site, Las Vegas
Novo Nordisk Investigational Site, Santa Monica
Novo Nordisk Investigational Site, Encino
Novo Nordisk Investigational Site, Escondido
Novo Nordisk Investigational Site, Poway
Novo Nordisk Investigational Site, Mission Viejo
Novo Nordisk Investigational Site, Tustin
Novo Nordisk Investigational Site, Orange
Novo Nordisk Investigational Site, Fresno
Novo Nordisk Investigational Site, Salinas
Novo Nordisk Investigational Site, Burlingame
Novo Nordisk Investigational Site, Concord
Novo Nordisk Investigational Site, Walnut Creek
Novo Nordisk Investigational Site, Honolulu
Novo Nordisk Investigational Site, Renton
Novo Nordisk Investigational Site, Bowling Green
Novo Nordisk Investigational Site, Berlin
Novo Nordisk Investigational Site, Lawrenceville
Novo Nordisk Investigational Site, Gallipolis
Novo Nordisk Investigational Site, Medford
Lead Sponsor
Novo Nordisk A/S
INDUSTRY